Hostname: page-component-78c5997874-fbnjt Total loading time: 0 Render date: 2024-11-05T14:23:30.570Z Has data issue: false hasContentIssue false

P0186 - Increasing cardiovascular mortality trends in schizophrenia in Sweden

Published online by Cambridge University Press:  16 April 2020

U. Osby
Affiliation:
Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden Research & Development Unit, Department of Psychiatry, Danderyd University Hospital, Danderyd, Sweden
L. Alfredsson
Affiliation:
Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden Stockholm Center for Public Health, Karolinska University Hospital, Stockholm, Sweden
G. Edman
Affiliation:
Research & Development Unit, Department of Psychiatry, Danderyd University Hospital, Danderyd, Sweden
J. Reutfors
Affiliation:
Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden Clinical Epidemiology Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden
G. Isacsson
Affiliation:
Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
C. Hennekens
Affiliation:
Department of Biomedical Science, Center of Excellence, Florida Atlantic University, Boca Raton, FL, USA
P. Sparen
Affiliation:
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Background:

Several studies from different countries demonstrate that cardiovascular mortality is the main cause of death for schizophrenia patients as well as for the population although patients with schizophrenia have a doubled cardiovascular mortality risk. The general population of Sweden has during recent years experienced remarkable declines in mortality from cardiovascular disease resulting in increased overall life expectancy. It is unclear whether patients with schizophrenia have experienced these benefits.

Methods:

Standardized mortality ratios (SMR) for schizophrenia patients in Sweden during 1970 through 2003 were analyzed, using data from national registers on diagnosis and causes of death. Secular trends for SMR were calculated in Poisson regression models.

Results:

SMR was for schizophrenia patients for all causes of death 2.33 for men and 2.35 for women, cardiovascular death 2.08 for men and 2.15 for women, coronary heart disease 1.91 for men and 2.06 for women, and for myocardial infarction 1.75 for men and 1.86 for women. Age-standardized mortality ratios for schizophrenia patients increased significantly (p<0.001) for both men and women for all causes of death, cardiovascular disease, coronary heart disease and acute myocardial infarction. Among schizophrenia patients, there were 3,410 excess deaths from cardiovascular causes.

Conclusion:

The substantial improvements in recent years in mortality from cardiovascular disorders in the general population were not observed among patients with schizophrenia. For the medical care system and for psychiatry the increasing differences in mortality from cardiovascular disease between the general population and patients with schizophrenia are a major clinical and public health concern.

Type
Poster Session I: Schizophrenia and Psychosis
Copyright
Copyright © European Psychiatric Association 2008
Submit a response

Comments

No Comments have been published for this article.